Jesse Goodman

About Jesse Goodman

Jesse Goodman is a director at Intellia Therapeutics.

Form D filings name Jesse Goodman as a director at Adaptive Phage Therapeutics.

Jesse Goodman reports to the SEC as a director of 2 public companies, including BiomX (PHGE).

Jesse Goodman first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Jesse Goodman in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Jesse Goodman works with at each company, as listed on that company's latest Form D.

Sources

1. SECAdaptive Phage Therapeutics, Inc. Form D, filed Jun 9, 2023
2. SECForms 3, 4 and 5 filed by Jesse Goodman (SEC filer 1756929)